ArticleIJID regions2026
High-risk human papillomavirus co-infection with other sexually transmitted infections and its association with cervical precancerous lesions in Ethiopian women: A cross-sectional study.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to determine the prevalence of high-risk human papillomavirus (hrHPV) and other sexually transmitted infection (STI) co-infections and assess their association with cervical cytological abnormalities among Ethiopian women aged 30-65 years. Methods: A facility-based cross-sectional study was conducted from May 2024 to March 2025 among 735 women attending 11 public health facilities found in six regions of Ethiopia. Cervical cytology, serological, and molecular tests were performed to detect hrHPV, HIV, syphilis, Results: Overall, 37.6% (95% confidence interval: 34.1-41.1%) of women had at least one type of STI; hrHPV was detected in 16.2%, HIV in 18.6%, syphilis in 5.0%, and CT in 3.7%. Cytological abnormalities were present in 5.7% of women, with 40.5% hrHPV positive. Among women positive for hrHPV, 42.1% had one or more STI co-infection, most commonly HIV (24.5%), syphilis (5.0%), and CT (4.2%). hrHPV/STI co-infection was strongly associated with cervical abnormalities (adjusted odds ratio = 5.85, 95% confidence interval: 2.68-12.74, Conclusion: Co-infections of hrHPV and other non-HPV STIs are common and strongly associated with cervical precancerous lesions. Integrating STI screening into cervical cancer prevention programs may improve early detection and reduce disease progression in Ethiopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.